Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INMEST via Walther System for Dry Eye Symptom Relief
NCT05887336Completed
- Sponsor
- Abilion Medical Systems
- Start
- Jun 2023
- Primary completion
- Aug 2024
- Countries
- 2
01
Overview
Randomised, double-blind trial in dry eye syndrome (DED) (2 arms), sponsored by Abilion Medical Systems. Primary endpoint: Change in Ocular Surface Disease Index at 6 weeks. Started Jun 2023; status: completed.
02
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT05887336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05887336.